Inhibrxinc Stock Shares Outstanding
| INBX Stock | USD 34.45 0.16 0.46% |
InhibrxInc fundamentals help investors to digest information that contributes to InhibrxInc's financial success or failures. It also enables traders to predict the movement of InhibrxInc Stock. The fundamental analysis module provides a way to measure InhibrxInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InhibrxInc stock.
Common Stock Shares Outstanding is likely to drop to about 38.2 M in 2024. InhibrxInc | Shares Outstanding |
InhibrxInc Company Shares Outstanding Analysis
InhibrxInc's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current InhibrxInc Shares Outstanding | 47.39 M |
Most of InhibrxInc's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InhibrxInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
InhibrxInc Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for InhibrxInc is extremely important. It helps to project a fair market value of InhibrxInc Stock properly, considering its historical fundamentals such as Shares Outstanding. Since InhibrxInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of InhibrxInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of InhibrxInc's interrelated accounts and indicators.
Click cells to compare fundamentals
InhibrxInc Shares Outstanding Historical Pattern
Today, most investors in InhibrxInc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various InhibrxInc's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of InhibrxInc shares outstanding as a starting point in their analysis.
InhibrxInc Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
InhibrxInc Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, InhibrxInc has 47.39 M of shares currently outstending. This is 73.75% lower than that of the Biotechnology sector and 55.65% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 91.71% higher than that of the company.
InhibrxInc Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InhibrxInc's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InhibrxInc could also be used in its relative valuation, which is a method of valuing InhibrxInc by comparing valuation metrics of similar companies.InhibrxInc is currently under evaluation in shares outstanding category among related companies.
InhibrxInc Fundamentals
| Return On Equity | -4.75 | ||||
| Return On Asset | -0.46 | ||||
| Operating Margin | (54.03) % | ||||
| Current Valuation | 1.57 B | ||||
| Shares Outstanding | 47.39 M | ||||
| Shares Owned By Insiders | 19.57 % | ||||
| Shares Owned By Institutions | 86.55 % | ||||
| Number Of Shares Shorted | 2.15 M | ||||
| Price To Book | 38.11 X | ||||
| Price To Sales | 920.99 X | ||||
| Revenue | 1.8 M | ||||
| Gross Profit | (107.99 M) | ||||
| EBITDA | (218.03 M) | ||||
| Net Income | (241.36 M) | ||||
| Cash And Equivalents | 176.38 M | ||||
| Cash Per Share | 4.52 X | ||||
| Total Debt | 210.14 M | ||||
| Debt To Equity | 4.22 % | ||||
| Current Ratio | 7.51 X | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | (193.31 M) | ||||
| Short Ratio | 3.41 X | ||||
| Earnings Per Share | (5.12) X | ||||
| Target Price | 35.5 | ||||
| Number Of Employees | 166 | ||||
| Beta | 2.92 | ||||
| Market Capitalization | 1.64 B | ||||
| Total Asset | 307.89 M | ||||
| Retained Earnings | (613.73 M) | ||||
| Working Capital | 239.05 M | ||||
| Net Asset | 307.89 M |
About InhibrxInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InhibrxInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InhibrxInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InhibrxInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out InhibrxInc Piotroski F Score and InhibrxInc Altman Z Score analysis. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.